MUHC research news
The Research Institute of the MUHC and McGill University have received a number of CIHR grants to support student recruitment and training.
When faced with patients suffering a heart attack, doctors have two choices: inject them with medication to dissolve the blood clot (fibrinolytic therapy) or insert a small balloon to open the blocked artery (primary percutaneous coronary intervention (PCI)). Guidelines for treating heart attacks are generally based on clinical trials that do not take “real-life” conditions into account.
A discovery by a team of Canadian and American researchers could provide new ways to fight HIV-AIDS. According to a new study published in Nature Medicine, HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments.
The story of Dr. Jekyll and Mr. Hyde, about the positive and negative aspects of the same person, could also apply to proteins. Cellular inhibitor of apoptosis proteins (IAPs), are known to have negative effects by promoting the development of many cancers.
Cocaine is one of the oldest drugs known to humans, and its abuse has become widespread since the end of the 19th century. At the same time, we know rather little about its effects on the human brain or the mechanisms that lead to cocaine addiction.
Le ministre de la Santé et des Services sociaux, le docteur Yves Bolduc, en présence du député de Marquette, monsieur François Ouimet, a annoncé un investissement de 29 millions de dollars sur trois ans pour augmenter le volume d’intervention en chirurgie bariatrique,
Dr. Sam Daniel of The Montreal Children’s Hospital of the MUHC Receives Canada’s Top 40 Under 40 Award
The Montreal Children’s Hospital of the McGill University Health Centre is pleased to announce that Dr. Sam Daniel, Director Otolaryngology Head and Neck Surgery, is a recipient ofCanada’s Top 40 Under 40 TM for 2008.